US Regulators Scrutinize Definition of “Healthy” on Labeling
29 Sep 2016 --- The word “healthy” is coming under closer scrutiny as the US Food and Drug Administration (FDA) starts a public process to redefine how it can be used as a nutrient content claim on labeling.
Redefining “healthy” is part of a plan to give consumers better information and tools to quickly and easily make food choices that are consistent with public health recommendations as well as encouraging the food industry to develop healthier food options.
At this stage food manufacturers can still use “healthy” on foods that meet the current regulatory definition, but that could change as public health recommendations for various nutrients have evolved.
FDA is issuing a document - Guidance for Industry: Use of the Term “Healthy” in the Labeling of Human Food Products - which says it does not intend to enforce the regulatory requirements for products that use the term if certain criteria are met.
The 2015-2020 Dietary Guidelines for Americans and the updated Nutrition Facts label reflect up to date thinking towards what is and is not considered healthy. For instance, healthy dietary patterns now focus on food groups, the type of fat rather than the total amount of fat consumed and also address added sugars in the diet.
Also, the nutrients of public health concern that consumers aren’t getting enough of have changed. FDA is publishing a “request for information” to solicit public input as it redefines the term “healthy.” In addition, the Agency is planning other public forums to receive additional public input.
The comment period started is now open.
Meanwhile FDA guidance also advises manufacturers of the intention to “exercise enforcement discretion” relative to foods to that use the implied nutrient content claim “healthy” on their labels which are either not low in total fat, but have a fat profile makeup of predominantly mono and polyunsaturated fats or contain at least 10 percent of the Daily Value (DV) per reference amount customarily consumed of potassium or vitamin D.
This is the FDA’s current thinking, is immediately effective guidance and is not to part of the public consultation, as it only a recommendation by the Administration.
